Clinical trial
Feasibility of ReSpace™ Hydrogel to Establish a Stable Cervical-rectal Space
NCT05369221 is registered in ClinicalTrials.gov with Peking Union Medical College Hospital as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Feasibility of ReSpace™ Hydrogel to Establish a Stable Cervical-rectal Space
- Lead sponsor
- Peking Union Medical College Hospital
- Phase
- Phase 1
- Overall status
- Completed
- Start date
- April 25, 2022
- Completion date
- October 10, 2023
- Enrollment
- 8 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.